Oncology Institute (TOIIW) Non-Current Assets (2019 - 2026)

Oncology Institute has reported Non-Current Assets for 8 years, with the latest figure at $51.4 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 10.17% year-over-year to $51.4 million; the trailing twelve-month figure through Mar 2026 stood at $211.8 million (down 13.06% YoY), and the FY2025 full-year result was $51.9 million, down 13.91% from the prior year.
• Non-Current Assets for Q1 2026 stood at $51.4 million, down from $51.9 million in the prior quarter.
• The five-year high for Non-Current Assets was $140.2 million in Q3 2022, with the low at $51.4 million in Q1 2026.
• Historically, Non-Current Assets has averaged $76.9 million across 5 years, with a median of $63.4 million in 2024.
• The largest YoY upside for Non-Current Assets was 165.77% in 2022 against a maximum downside of 71.05% in 2022.
• Oncology Institute's Non-Current Assets stood at $131.2 million in 2022, then tumbled by 49.91% to $65.7 million in 2023, then slipped by 8.29% to $60.3 million in 2024, then retreated by 13.91% to $51.9 million in 2025, then retreated by 1.04% to $51.4 million in 2026.
• The last three Non-Current Assets figures came in at $51.4 million (Q1 2026), $51.9 million (Q4 2025), and $53.5 million (Q3 2025), per Business Quant data.